213 related articles for article (PubMed ID: 6375015)
1. An apparent paradoxical effect of pretransplant blood transfusions. Its association with decreased anti-HLA antibody formation following unsuccessful renal transplantation.
Lobo PI
Transplantation; 1984 Jun; 37(6):562-4. PubMed ID: 6375015
[TBL] [Abstract][Full Text] [Related]
2. Anti-class II antibody production prolongs renal allograft survival.
Lewis RE; Brackin MN; Cruse JM; Brackin BT; Butkus D; Raju S; Crawford M; Krueger R; Kirchner K; Bower J
Pathol Immunopathol Res; 1989; 8(5-6):287-99. PubMed ID: 2633201
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of HLA-A and B matched pretransplant blood transfusions on primary cadaveric kidney graft survival.
Nubé MJ; Persijn GG; van Es A; Kalff MW; de Graeff J; van Rood JJ
Transplantation; 1983 Jun; 35(6):556-61. PubMed ID: 6346596
[TBL] [Abstract][Full Text] [Related]
4. Pretransplant serum BAFF levels are associated with pretransplant HLA immunization and renal allograft survival.
Friebus-Kardash J; Wilde B; Keles D; Heinold A; Kribben A; Witzke O; Heinemann FM; Eisenberger U
Transpl Immunol; 2018 Apr; 47():10-17. PubMed ID: 29277566
[TBL] [Abstract][Full Text] [Related]
5. Antithymocyte globulin, pretransplant blood transfusion, and tissue typing in cadaver kidney transplantation.
Cho SI; Bradley JW; Carpenter CB; Cosimi AB; Monaco AP
Am J Surg; 1983 Apr; 145(4):464-71. PubMed ID: 6340551
[TBL] [Abstract][Full Text] [Related]
6. Influence of HLA disparity, immunosuppressive regimen used, and type of kidney allograft on production of anti-HLA class-I antibodies after transplant and occurrence of rejection.
Abdelnoor AM; Ajib R; Chakhtoura M; Daouk M; Medawar W; Uwaydah M; Sawah SI; Khauli RB
Immunopharmacol Immunotoxicol; 2009; 31(1):83-7. PubMed ID: 18752168
[TBL] [Abstract][Full Text] [Related]
7. Effect of HLA-DR matching between living kidney donors and recipients and of pretransplant blood transfusions on graft survival.
Akiyama N; Sugimoto H; Kusaba R; Takahashi I; Ohsawa N; Inou T; Samaru Y
Jpn J Exp Med; 1981 Feb; 51(1):37-43. PubMed ID: 6458714
[TBL] [Abstract][Full Text] [Related]
8. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
[TBL] [Abstract][Full Text] [Related]
9. [Organ transplantation and blood transfusion].
Matignon M; Bonnefoy F; Lang P; Grimbert P
Transfus Clin Biol; 2011 Apr; 18(2):70-8. PubMed ID: 21398160
[TBL] [Abstract][Full Text] [Related]
10. The influence on pretransplant blood transfusions from random donors on immune parameters affecting cadaveric allograft survival.
Kerman RH; Van Buren CT; Payne W; Flechner S; Agostino G; Conley S; Brewer E; Kahan BD
Transplantation; 1983 Jul; 36(1):50-4. PubMed ID: 6223421
[TBL] [Abstract][Full Text] [Related]
11. Pretransplant exposure to donor HLA-DR antigen in random transfusion units and the development of donor antigen-specific hyporeactivity.
Jackson A; McSherry C; Butters K; Diko M; Almond PS; Matas AJ; Reinsmoen NL
Hum Immunol; 1997 Jul; 55(2):148-53. PubMed ID: 9361966
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
[TBL] [Abstract][Full Text] [Related]
13. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
[TBL] [Abstract][Full Text] [Related]
14. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
15. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine.
Kerman RH; van Buren CT; Lewis RM; Frazier OH; Cooley D; Kahan BD
Transplantation; 1988 Feb; 45(2):333-7. PubMed ID: 3278425
[TBL] [Abstract][Full Text] [Related]
16. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
17. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
[TBL] [Abstract][Full Text] [Related]
18. Possible mechanism of the beneficial effect of pretransplant blood transfusions on renal allograft survival in man.
Singal DP; Joseph S; Szewczuk MR
Transplant Proc; 1982 Jun; 14(2):316-8. PubMed ID: 6214059
[No Abstract] [Full Text] [Related]
19. Transplant survival and clinical course after pretransplant HLA-A and B matched blood transfusions: a single centre study.
Nubé MJ; Persijn GG; Kalff MW; van Es A; de Graeff J; von Rood JJ
Proc Eur Dial Transplant Assoc; 1983; 19():445-52. PubMed ID: 6348745
[TBL] [Abstract][Full Text] [Related]
20. Blood transfusions and HLA matching--an either/or situation in cadaveric renal transplantation.
Cecka JM; Cicciarelli J; Mickey MR; Terasaki PI
Transplantation; 1988 Jan; 45(1):81-6. PubMed ID: 3276068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
